1. Home
  2. RCKT vs NNDM Comparison

RCKT vs NNDM Comparison

Compare RCKT & NNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • NNDM
  • Stock Information
  • Founded
  • RCKT 1999
  • NNDM 2012
  • Country
  • RCKT United States
  • NNDM United States
  • Employees
  • RCKT N/A
  • NNDM N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • NNDM Electrical Products
  • Sector
  • RCKT Health Care
  • NNDM Technology
  • Exchange
  • RCKT Nasdaq
  • NNDM Nasdaq
  • Market Cap
  • RCKT 328.6M
  • NNDM 334.6M
  • IPO Year
  • RCKT N/A
  • NNDM N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • NNDM $1.40
  • Analyst Decision
  • RCKT Buy
  • NNDM
  • Analyst Count
  • RCKT 13
  • NNDM 0
  • Target Price
  • RCKT $12.96
  • NNDM N/A
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • NNDM 1.4M
  • Earning Date
  • RCKT 08-07-2025
  • NNDM 09-09-2025
  • Dividend Yield
  • RCKT N/A
  • NNDM N/A
  • EPS Growth
  • RCKT N/A
  • NNDM N/A
  • EPS
  • RCKT N/A
  • NNDM N/A
  • Revenue
  • RCKT N/A
  • NNDM $58,812,000.00
  • Revenue This Year
  • RCKT N/A
  • NNDM N/A
  • Revenue Next Year
  • RCKT $108.43
  • NNDM N/A
  • P/E Ratio
  • RCKT N/A
  • NNDM N/A
  • Revenue Growth
  • RCKT N/A
  • NNDM 7.49
  • 52 Week Low
  • RCKT $2.19
  • NNDM $1.31
  • 52 Week High
  • RCKT $22.01
  • NNDM $2.74
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • NNDM 50.50
  • Support Level
  • RCKT $2.88
  • NNDM $1.39
  • Resistance Level
  • RCKT $3.74
  • NNDM $1.45
  • Average True Range (ATR)
  • RCKT 0.27
  • NNDM 0.05
  • MACD
  • RCKT 0.02
  • NNDM 0.01
  • Stochastic Oscillator
  • RCKT 35.43
  • NNDM 69.12

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

Share on Social Networks: